68Ga-FAPI-04 PET/CT Imaging for Fibrous Dysplasia of the Bone. (January 2022)

• Record Type: Journal Article
• Authors: Wang, Yingwei; Wu, Junhao; Liu, Lin; Peng, DengSai; Chen, Yue
• Is Part Of: Clinical nuclear medicine. Volume 47:Number 1(2022)
• Publication Date: 2022-01
• Subjects: 68Ga-FAPI -- fibrous dysplasia -- PET/CT; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000003896
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Abstract: 68 Ga-labeled quinoline-based fibroblast activation protein inhibitors ( 68 Ga-FAPIs) are promising agents for tumor imaging. However, some nonneoplastic lesions can also cause increased FAPI uptake. We report a case of a patient with polyostotic fibrous dysplasia who showed widespread and intense metabolic activity on 68 Ga-FAPI PET/CT. Physicians should be aware that fibrous dysplasia can also cause elevated FAPI activity.